Unlike the conventional chemotherapeutic agents that primarily target the tumor cells, CA-4 disrupts the tumor’s blood vessels, cutting off oxygen and nutrient supply, and leading to rapid necrosis of the central tumor mass. Here, CA4 is linked to neoplasm.